139-88-8
139-88-8
Chemical Structure
Sodium tetradecyl sulfate (27% in water)
Synonym(s): Tergitol 4
- CAS No.: 139-88-8
- Formula:C14H29NaO4S
- Molecular Weight:316.43
IUPAC Name: sodium 7-ethyl-2-methylundecan-4-yl sulfate
InChIKey: FVEFRICMTUKAML-UHFFFAOYSA-M
SMILES: O=S(OC(CC(C)C)CCC(CCCC)CC)(O[Na])=O
Biological Activity: Sodium tetradecyl sulfate (Tergitol 4) is a novel scleroembolic agent and an apoptosis inducer. Sodium tetradecyl sulfate can be used for research on varicose veins and vascular malformation diseases[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sodium tetradecyl sulfate (27% in water) | 99.54% | Sodium tetradecyl sulfate (Tergitol 4) is a novel scleroembolic agent and an apoptosis inducer. Sodium tetradecyl sulfate can be used for research on varicose veins and vascular malformation diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Connor DE, et al. Sirolimus and propranolol inhibit endothelial proliferation while detergent sclerosants induce endothelial activation, microparticle release and apoptosis in vitro. Phlebology. 2020 Sep;35(8):566-575. [Content Brief]
- [2]. Zehtabi F, et al. Chitosan-Sodium Tetradecyl Sulfate Hydrogel: Characterization and Preclinical Evaluation of a Novel Sclerosing Embolizing Agent for the Treatment of Endoleaks. Cardiovasc Intervent Radiol. 2017 Apr;40(4):576-584. [Content Brief]
- [3]. Morsiani E, et al. Effect of intravenous and intraperivenous injections of sclerosants (sodium tetradecyl sulfate and hydroxy polyethoxy dodecan) on the rat femoral vein. Res Exp Med (Berl). 1987;187(6):439-49. [Content Brief]
